PriceSensitive

Atlas Arteria (ASX:ALX) completes $420M placement

ASX 200
ASX:ALX      MCAP $7.152B
29 May 2020 14:30 (AEST)
Atlas Arteria (ASX:ALX) - CEO, Graeme Bevans

Source: Financial Review

Despite only being announced yesterday, toll road operator Atlas Arteria (ALX) has successfully completed a $420 million placement.

Approximately 67.7 million new fully paid shares were issued to domestic and offshore institutional investors at a price of $6.20 per share.

This price represented a 7.5 per cent discount to the last trading price of $6.70 on May 27, and an 8.2 per cent discount to the five-day volume-weighted average price up to close on May 27, which hit $6.76.

As the placement was oversubscribed, shareholders who bid for an amount either less or equal than their pro-rata amount received what they applied for.

Shares under the placement are expected to settle on June 2 and be allocated and begin trading the ASX on June 3.

Atlas Arteria will use this money to boost its finances after motorists stayed home during the COVID-19 pandemic and did not pay tolls and repay a loan to MIBL Finance of Luxembourg.

“We are very pleased with the significant support for the transaction. The repayment of the MIBL Facility will deliver a stronger, more resilient balance sheet and improve our flexibility to pursue future growth opportunities,” CEO Graeme Bevans said.

Atlas Arteria will now undertake a share purchase plan to raise an additional $75 million.

The share purchase plan will open on June 5, close on June 25, and shares can begin trading on the ASX on July 3.

Atlas Arteria is down a slight 2.09 per cent on the market and shares are trading for $6.56 each at 2:29 pm AEST.

Related News